Peter F. Weller

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

Michael E. Wechsler, Praveen Akuthota, David Jayne et al. · New England Journal of Medicine · 2017 · 1.1K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes

Peter Valent, Amy D. Klion, Hans‐Peter Horny et al. · Journal of Allergy and Clinical Immunology · 2012 · 761 citations · Full text

Medicine, Pathology, Dermatopathology +8

Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy

Princess U. Ogbogu, Bruce S. Bochner, Joseph H. Butterfield et al. · Journal of Allergy and Clinical Immunology · 2009 · 621 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +5

Treatment of Patients with the Hypereosinophilic Syndrome with Mepolizumab

Marc E. Rothenberg, Amy D. Klion, Florence Roufosse et al. · New England Journal of Medicine · 2008 · 575 citations · Full text

Life Sciences, Clinical Sciences, Pharmacotherapy +7

Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.

Peter F. Weller, C W Lee, Donald W. Foster et al. · Proceedings of the National Academy of Sciences · 1983 · 484 citations · Full text

Life Sciences, Immunology, Pharmacology +14